Annovis Bio, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number
Annovis Bio, Inc. (ANVS) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number of 1.28 million shares as of 2022-09-30, per its 10-Q filed 2022-11-08.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber · last filed 2022-11-08
- 2022-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number 1.28M shares.
- 2022-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number 1.24M shares.
- 2022-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number 1.21M shares.
- 2021-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number 1.11M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number |
|---|---|
| 2022-09-30 | 1.28M shares 10-Q · filed 2022-11-08 |
| 2022-06-30 | 1.24M shares 10-Q · filed 2022-08-08 |
| 2022-03-31 | 1.21M shares 10-Q · filed 2022-05-04 |
| 2021-12-31 | 1.11M shares 10-Q · filed 2022-11-08 |
| 2021-09-30 | 951.65K shares 10-Q · filed 2021-11-03 |
| 2021-03-31 | 1.06M shares 10-Q · filed 2021-05-06 |
| 2020-12-31 | 1.06M shares 10-Q · filed 2021-11-03 |
| 2020-09-30 | 1.06M shares 10-Q · filed 2020-11-04 |
| 2020-06-30 | 853.85K shares 10-Q · filed 2020-07-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |